Abstract
Purpose To determine the relationship between anthropometric measures and corneal refractive power (CRP).
Methods Participants from the 1999-2008 United States National Health and Nutrition Examination Survey (NHANES) visual exam with demographic, ocular, and anthropometric data (20,165 subjects) were included. Cases with steep cornea were defined by corneal power ≥ 48.0 diopters (n = 171) while controls had dioptric power < 48.0 D (n = 19,994). Multivariable analyses were performed for pooled and sex-stratified populations. Separate models assessed body mass index, height, and weight in relation to steep cornea.
Results A relationship between BMI and steep cornea in the pooled population was not detected (P for trend = 0.78). There was a strong inverse relationship between height and steep cornea in the pooled population (P for trend <0.0001) and women (P for trend <0.0001). For every 1-inch increase in height, there was a 16% reduced odds of steep cornea in the pooled population (OR, 0.84; 95% CI: 0.78-0.91). There was also a significant inverse relationship between weight and steep cornea in the pooled population (P for trend = 0.01) and in men (P for trend = 0.02). For each 10-pound increase in weight there was a 7% reduced odds of steep cornea (OR, 0.927; 95% CI: 0.882-0.975) in the pooled analysis.
Conclusions Greater height and greater weight were associated with a lower risk of steep cornea. These findings can contribute to an improved understanding of the pathogenesis of corneal ectasias.
Competing Interest Statement
Dr. Pasquale is supported by NEI EY015473 and the New York Eye and Ear Infirmary Foundation. He is a consultant to Eyenovia, Twenty-twenty and Skye Biosciences. Dr. Ahmad is supported by the New York Eye and Ear Infirmary Foundation.
Funding Statement
Dr. Ahmad is supported by the New York Eye and Ear Infirmary Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was deemed exempt from IRB approval by the Icahn School of Medicine at Mount Sinai IRB .
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
COI: Dr. Pasquale is supported by NEI EY015473 and the New York Eye and Ear Infirmary Foundation. He is a consultant to Eyenovia, Twenty-twenty and Skye Biosciences. Dr. Ahmad is supported by the New York Eye and Ear Infirmary Foundation.
Data Availability
We used data from the 1999-2008 National Health and Nutrition Examination Survey (NHANES). The NHANES has been described previously. Briefly, it is a nationally representative survey of the US civilian, noninstitutionalized population with data on demographics, lifestyle, anthropometric measures, and also ocular health (see citation below). Engel A, Murphy RS, Maurer K, Collins E. Plan and operation of the HANES I augmentation survey of adults 25-74 years United States, 1974-1975 - PubMed. Accessed December 19, 2020. https://pubmed-ncbi-nlm-nih-gov.eresources.mssm.edu/695333/
